Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
63
NCT05221827
Clinical Performance Evaluation of the C2i-Test
Phase: N/A
Role: Lead Sponsor
Start: Feb 24, 2022
Completion: Jul 27, 2022
NCT05629442
ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer
Role: Collaborator
Start: Jan 31, 2023
Completion: Jun 30, 2030